Inventor
Hugh McTavish
Inventor
Birchwood, MN, US
Overview
Patents· 23 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Pprimary
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations19%
A61KPreparations for medical, dental or toiletry purposes17%
C07KPeptides13%
C12NMicroorganisms or enzymes9%
C12PFermentation or enzyme-using processes to synthesise a desired chemical compound or composition or to separate optical isomers from a racemic mixture9%
Y02EReduction of greenhouse gas [ghg] emissions, related to energy generation, transmission or distribution7%
C02FTreatment of water, waste water, sewage, or sludge4%
C07CAcyclic or carbocyclic compounds4%
C12MApparatus for enzymology or microbiology4%
Y02WClimate change mitigation technologies related to wastewater treatment or waste management4%
PatentTitleYear
10,967,049Fusion proteins containing insulin-like growth factor-1 and epidermal growth factor and variants thereof and uses thereof202110,940,197Non-specific delayed-type hypersensitivity response to treat herpes simplex virus infection202110,744,084Non-specific delayed-type hypersensitivity response to treat herpes simplex virus infection202010,391,147Fusion proteins containing insulin-like growth factor-1 and epidermal growth factor and variants thereof and uses thereof201910,245,314Non-specific delayed-type hypersensitivity response to treat herpes simplex virus infection20199,801,923'Fusion proteins containing insulin-like growth factor-1 and epidermal growth factor and variants thereof and uses thereof'20179,675,671'Fusion proteins containing insulin-like growth factor-1 and epidermal growth factor and variants thereof and uses thereof'20179,205,065'Non-specific delayed-type hypersensitivity response to treat herpes simplex virus infection'20159,011,880'Compounds and methods for treating cancer'20158,920,777'Toxins and radionuclides coupled to IGF-1 receptor ligands for treatment of cancer'20148,501,906'Compounds and methods for treating cancer'20138,017,102'Toxins and radionuclides coupled to IGF-1 receptor ligands for treatment of cancer'20118,016,700'Tennis backboard'20117,919,290'Bio-recycling of carbon dioxide emitted from power plants'20117,811,982'Compounds and methods for treating cancer'20107,687,250'Ethanol production from biological wastes'20107,677,993'Tennis backboard'20107,622,285'Ethanol production from biological wastes'20097,608,439'Bio-recycling of carbon dioxide emitted from power plants'20097,309,592'Ethanol production from biological wastes'20076,919,199'Microbes and methods for remediation'20056,673,582'Microbes and methods for remediation'20046,410,258'Molecular hydrogen production by direct electron transfer'2002Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2002Based in St. Paul, MN, US· patent location history
2004–2015Based in Birchwood, MN, US· patent location history
2007–2010Patents assigned to NOVUS ENERGY LLC (2)· patent assignee history
2009–2017Patents assigned to MCTAVISH HUGH (8)· patent assignee history
2009–2011Patents assigned to OFFERMAN JOHN D (3)· patent assignee history
2010–2021Patents assigned to IGF ONCOLOGY LLC (9)· patent assignee history
2015–2021Patents assigned to SQUAREX LLC (4)· patent assignee history
2015–2021Based in Pine Springs, MN, US· patent location history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| IGF ONCOLOGY LLC | 9 | 2010–2021 |
| MCTAVISH HUGHself | 8 | 2009–2017 |
| SQUAREX LLC | 4 | 2015–2021 |
| OFFERMAN JOHN D | 3 | 2009–2011 |
| NOVUS ENERGY LLC | 2 | 2007–2010 |
Locations
| Location | Patents | Span |
|---|---|---|
| Birchwood, Minnesota, US | 14 | 2004–2015 |
| Pine Springs, Minnesota, US | 8 | 2015–2021 |
| St. Paul, Minnesota, US | 1 | 2002 |